Skip to main content

Published locations for Daclizumab beta may be superior to interferon beta on MS disability progression

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Daclizumab beta may be superior to interferon beta on MS disability progression

User login

  • Reset your password
  • /content/daclizumab-beta-may-be-superior-interferon-beta-ms-disability-progression
  • /neurologyreviews/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon-beta
  • /multiplesclerosishub/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon
  • /neurology/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon-beta-ms
  • /neurology/msresourcecenter/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior
  • /breast-cancer-icymi/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon
  • /b-cell-lymphoma-icymi/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon
  • /clinicalneurologynews/article/192320/multiple-sclerosis/daclizumab-beta-may-be-superior-interferon